Seeing Is Believing
Healthcare - Sector
Blueprint Medicines Corp's activity chart (see below) currently has 340 price targets and 248 ratings on display.
Analysts average stock forecasts to be materialized ratio is 77.27% with an average time for these price targets to be met of 258.21 days.
Most recent stock forecast was given by DEREK ARCHILA from WELLS FARGO on 17-Jun-2025. First documented stock forecast 26-May-2015.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Buy Since 27-Oct-2023
$129
$-0.46 (-0.36%)
$151
1 years 2 months 24 days ago
(17-Jun-2025)
10/11 (90.91%)
$0.77 (0.60%)
110
Hold Since 24-Oct-2024
$129
$-0.46 (-0.36%)
$88
1 years 3 months 5 days ago
(05-Jun-2025)
2/2 (100%)
$1.1 (0.86%)
21
Hold Since 20-Mar-2025
$129
$-0.46 (-0.36%)
$102
1 years 3 months 5 days ago
(05-Jun-2025)
3/3 (100%)
$1.1 (0.86%)
27
Sell Since 10-Jun-2022
$129
$-0.46 (-0.36%)
$83
1 years 3 months 6 days ago
(04-Jun-2025)
14/17 (82.35%)
$0.9 (0.70%)
197
Buy Since 14-May-2024
$135
$5.54 (4.28%)
$140
1 years 3 months 7 days ago
(03-Jun-2025)
0/3 (0%)
$7.4 (5.80%)
What is BPMC (Blueprint Medicines Corp) average time for price targets to be met?
Which analyst most recently updated their price target on BPMC (Blueprint Medicines Corp)?
Which analyst has the most public recommendations on BPMC (Blueprint Medicines Corp)?
Which analyst is the currently most bullish on BPMC (Blueprint Medicines Corp)?
Which analyst is the currently most reserved on BPMC (Blueprint Medicines Corp)?